Preclinical drug development must consider the impact on metastasis

Patricia S. Steeg; Robin L. Anderson; Menashe Bar-Eli; Ann F. Chambers; Suzanne A. Eccles; Kent Hunter; Kazuyuki Itoh; Yibin Kang; Lynn M. Matrisian; Jonathan P. Sleeman; Dan Theodorescu; Erik W. Thompson; Danny R. Welch

doi:10.1158/1078-0432.CCR-09-1363

Preclinical drug development must consider the impact on metastasis

Patricia S. Steeg, Robin L. Anderson, Menashe Bar-Eli, Ann F. Chambers, Suzanne A. Eccles, Kent Hunter, Kazuyuki Itoh, Yibin Kang, Lynn M. Matrisian, Jonathan P. Sleeman, Dan Theodorescu, Erik W. Thompson, Danny R. Welch

Research output: Contribution to journal › Short survey › peer-review

32 Scopus citations

Original language	English (US)
Pages (from-to)	4529-4530
Number of pages	2
Journal	Clinical Cancer Research
Volume	15
Issue number	14
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-1363
State	Published - Jul 15 2009

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-09-1363

Cite this

@article{da82d222872f4343a63c4a0df84f8aff,

title = "Preclinical drug development must consider the impact on metastasis",

author = "Steeg, \{Patricia S.\} and Anderson, \{Robin L.\} and Menashe Bar-Eli and Chambers, \{Ann F.\} and Eccles, \{Suzanne A.\} and Kent Hunter and Kazuyuki Itoh and Yibin Kang and Matrisian, \{Lynn M.\} and Sleeman, \{Jonathan P.\} and Dan Theodorescu and Thompson, \{Erik W.\} and Welch, \{Danny R.\}",

year = "2009",

month = jul,

day = "15",

doi = "10.1158/1078-0432.CCR-09-1363",

language = "English (US)",

volume = "15",

pages = "4529--4530",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "14",

}

TY - JOUR

T1 - Preclinical drug development must consider the impact on metastasis

AU - Steeg, Patricia S.

AU - Anderson, Robin L.

AU - Bar-Eli, Menashe

AU - Chambers, Ann F.

AU - Eccles, Suzanne A.

AU - Hunter, Kent

AU - Itoh, Kazuyuki

AU - Kang, Yibin

AU - Matrisian, Lynn M.

AU - Sleeman, Jonathan P.

AU - Theodorescu, Dan

AU - Thompson, Erik W.

AU - Welch, Danny R.

PY - 2009/7/15

Y1 - 2009/7/15

UR - https://www.scopus.com/pages/publications/68049083836

UR - https://www.scopus.com/inward/citedby.url?scp=68049083836&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-09-1363

DO - 10.1158/1078-0432.CCR-09-1363

M3 - Short survey

C2 - 25278743

AN - SCOPUS:68049083836

SN - 1078-0432

VL - 15

SP - 4529

EP - 4530

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 14

ER -

Preclinical drug development must consider the impact on metastasis

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this